Robert Verity
Biographic Data
| ID | 8852324 |
|---|---|
| NAME | Robert Verity |
| GIVEN NAMES | Robert |
| FAMILY NAME | Verity |
| SIGNATURE | VERITY R |
| AFFILIATIONS | Imperial College London |
| ORCID | 0000-0002-3902-8567 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 8 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1968 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Target product profiles of laboratory and data analytical frameworks for genotyping to monitor antimalarial efficacy
Therapeutic efficacy studies (TESs) are the standard to evaluate antimalarial drug efficacy and guide malaria treatment policy. TESs are particularly relevant now, with resistance to first-line regimens emerging in sub-Saharan Africa. For TESs, a range of parasite genotyping and data analyses are available for genotype correction, a process to distinguish whether recurrent parasitemia after therapy is due to recrudescence of initially infecting p…
Reduction in mobility and Covid-19 transmission
In response to the COVID-19 pandemic, countries have sought to control SARS-CoV-2 transmission by restricting population movement through social distancing interventions, thus reducing the number of contacts. Mobility data represent an important proxy measure of social distancing, and here, we characterise the relationship between transmission and mobility for 52 countries around the world. Transmission significantly decreased with the initial re…
Estimating the effects of non-pharmaceutical interventions on Covid-19 in Europe
The impact of Covid-19 and strategies for mitigation and suppression in low- and middle-income countries
Global prospects for COVID-19 control Lower-income countries have recognized the potential impact of coronavirus disease 2019 (COVID-19) from observing ongoing epidemics. Many have intervened quickly and early with measures to slow viral transmission, which may partly explain the low rates observed so far in these countries. Walker et al. calibrated a global model with country-specific data (see the Perspective by Metcalf et al. ). Despite the po…
Estimates of the severity of coronavirus disease 2019
BACKGROUND: In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. We aimed to provide robust estimates, accounting for censoring and ascertainment biases. METHODS: We collected individual-case data for patients who died from COVID-19 in Hubei, mainland China (reported by national and provincial health commissions to Feb 8, 2…
Potential impact of the Covid-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries
BACKGROUND: COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disruptions to services for HIV, tuberculosis, and malaria in low-income and middle-income countries with high burdens of these diseases could lead to additional loss of life over the next 5 years. METHODS: Assu…
Spatial and epidemiological drivers of Plasmodium falciparum malaria among adults in the Democratic Republic of the Congo
BACKGROUND: Adults are frequently infected with malaria and may serve as a reservoir for further transmission, yet we know relatively little about risk factors for adult infections. In this study, we assessed malaria risk factors among adults using samples from the nationally representative, cross-sectional 2013-2014 Demographic and Health Survey (DHS) conducted in the Democratic Republic of the Congo (DRC). We further explored differences in ris…
Notes and Commentary
No prominent works on this page.
Notes and Commentary
Estimating the effects of non-pharmaceutical interventions on Covid-19 in Europe
The impact of Covid-19 and strategies for mitigation and suppression in low- and middle-income countries
Global prospects for COVID-19 control Lower-income countries have recognized the potential impact of coronavirus disease 2019 (COVID-19) from observing ongoing epidemics. Many have intervened quickly and early with measures to slow viral transmission, which may partly explain the low rates observed so far in these countries. Walker et al. calibrated a global model with country-specific data (see the Perspective by Metcalf et al. ). Despite the po…
Estimates of the severity of coronavirus disease 2019
BACKGROUND: In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. We aimed to provide robust estimates, accounting for censoring and ascertainment biases. METHODS: We collected individual-case data for patients who died from COVID-19 in Hubei, mainland China (reported by national and provincial health commissions to Feb 8, 2…
Potential impact of the Covid-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries
BACKGROUND: COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disruptions to services for HIV, tuberculosis, and malaria in low-income and middle-income countries with high burdens of these diseases could lead to additional loss of life over the next 5 years. METHODS: Assu…
Spatial and epidemiological drivers of Plasmodium falciparum malaria among adults in the Democratic Republic of the Congo
BACKGROUND: Adults are frequently infected with malaria and may serve as a reservoir for further transmission, yet we know relatively little about risk factors for adult infections. In this study, we assessed malaria risk factors among adults using samples from the nationally representative, cross-sectional 2013-2014 Demographic and Health Survey (DHS) conducted in the Democratic Republic of the Congo (DRC). We further explored differences in ris…
Reduction in mobility and Covid-19 transmission
In response to the COVID-19 pandemic, countries have sought to control SARS-CoV-2 transmission by restricting population movement through social distancing interventions, thus reducing the number of contacts. Mobility data represent an important proxy measure of social distancing, and here, we characterise the relationship between transmission and mobility for 52 countries around the world. Transmission significantly decreased with the initial re…
Target product profiles of laboratory and data analytical frameworks for genotyping to monitor antimalarial efficacy
Therapeutic efficacy studies (TESs) are the standard to evaluate antimalarial drug efficacy and guide malaria treatment policy. TESs are particularly relevant now, with resistance to first-line regimens emerging in sub-Saharan Africa. For TESs, a range of parasite genotyping and data analyses are available for genotype correction, a process to distinguish whether recurrent parasitemia after therapy is due to recrudescence of initially infecting p…
Medicine (6 works) · Coronavirus disease 2019 (COVID-19) (5 works) · COVID-19 epidemiological studies (5 works) · Infectious disease (medical specialty) (4 works) · Internal Medicine (4 works) · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (4 works) · 2019-20 coronavirus outbreak (3 works) · COVID-19 Pandemic Impacts (3 works) · Disease (3 works) · Economic growth (3 works)